62224-24-2

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 4,5-DIBROMOTHIOPHENE-2-CARBOXYLATE is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, METHYL 4,5-DIBROMOTHIOPHENE-2-CARBOXYLATE is utilized in the production of pesticides and other crop protection agents. Its properties contribute to the effectiveness of these products in controlling pests and diseases, thereby ensuring healthier and more productive crops.
Used in Organic Synthesis:
METHYL 4,5-DIBROMOTHIOPHENE-2-CARBOXYLATE is employed as a versatile building block in organic synthesis. Its functional groups and reactivity enable the creation of a wide range of organic molecules for various applications, including materials science, chemical research, and the development of new compounds with specific properties.
Used in Research and Development:
Due to its potential applications across different industries, METHYL 4,5-DIBROMOTHIOPHENE-2-CARBOXYLATE is a valuable chemical for research and development purposes. It serves as a starting material for exploring new chemical reactions, discovering novel compounds, and advancing the understanding of chemical processes and mechanisms.

InChI:InChI=1/C6H4Br2O2S/c1-10-6(9)4-2-3(7)5(8)11-4/h2H,1H3

Upstream product

• 74-88-4 methyl iodide 
• 67-56-1 methanol 
• 6324-10-3 4,5-Dibromo-thiophene-2-carboxylic acid 

Downstream Products

• 6324-10-3 4,5-Dibromo-thiophene-2-carboxylic acid 
• 1047630-72-7 methyl 4-bromo-5-chlorothiophene-2-carboxylate 
• 918164-44-0 PdBr(P(C₆H₅)3)2C₄HSBrCOOCH₃ 
• 918164-37-1 methyl 4-bromo-5-(4-trifluoromethylphenyl)thiophene-2-carboxylate 
• 918164-38-2 methyl 4,5-bis(4-trifluoromethylphenyl)thiophene-2-carboxylate 

Relevant academic research and scientific papers

THIOPHENE, MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL APPLICATION OF SAME

The present invention discloses a thiophene used as a uric acid transporter (URAT1) inhibitor and applicantion of the thiophene in preparing a pharmaceutical product for treating a disease related to abnormal uric acid levels, specifically in preparing a pharmaceutical product for treating hyperuricemia and gouty arthritis. The invention specifically relates to a compound as represented by formula (I) or a pharmaceutically acceptable salt thereof.

Thieno[3,2-c]pyrazoles: A novel class of Aurora inhibitors with favorable antitumor activity

A novel series of 3-amino-1H-thieno[3,2-c]pyrazole derivatives demonstrating high potency in inhibiting Aurora kinases was developed. Here we describe the synthesis and a preliminary structure-activity relationship, which led to the discovery of a represe

Heterobicyclic pyrazole derivatives as kinase inhibitors

Bicyclo-pyrazoles of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in

Insights into the mechanism of the site-selective sequential palladium-catalyzed cross-coupling reactions of dibromothiophenes/ dibromothiazoles and arylboronic acids. Synthesis of PPARβ/δ agonists

A reactivity study, aided by NMR spectroscopy, allowed a mechanistic rationale to be postulated for the palladium-catalyzed regioselective coupling of arylboronic acid (and arylstannane where feasible) at the position next to the sulfur atom in functional

HETEROBICYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS

Bicyclo-pyrazoles of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in